The Tamil Nadu government has ordered an immediate ban on the sale and distribution of the popular ‘Coldrif’ cough syrup after reports linked its consumption to the deaths of several children in the state. The directive was issued on October 4, 2025, following investigations by state health authorities and the Food Safety and Drugs Administration (FDA). Preliminary reports suggest that the syrup may have contained contaminants or incorrect formulations, prompting urgent public health action. Hospitals in affected districts confirmed multiple cases of adverse reactions in children, leading to fatalities. Authorities have urged parents to immediately discontinue the use of the syrup and report any symptoms such as nausea, difficulty breathing, or convulsions to medical facilities. The FDA has launched a broader investigation into the manufacturer and is coordinating with central health agencies to ensure accountability and prevent further incidents. Meanwhile, hospitals and health departments are distributing alternative, safe medications and providing guidance to pediatricians and caregivers across Tamil Nadu. The state government has also called for a review of over-the-counter drug monitoring and quality assurance to prevent similar tragedies in the future. #TamilNadu #ColdrifBan #ChildSafety #DrugSafety #PediatricHealth #FDAIndia #PublicHealthAlert #MedicalSafety #HealthAuthorities #SafeMedication
